Back to search

Article

Comparison of the Incidence Rate of Radiation Pneumonitis Observed in Patients with Advanced Lung Adenocarcinoma Treated with Simultaneous Thoracic Radiotherapy and 1G/2G/3G EGFR-TKIs

2022-09-30

Abstract excerpt

<h4>Background: </h4> The present study aimed to evaluate the incidence rate of radiation pneumonitis (RP) in patients with stage III-IV lung adenocarcinoma treated with first-generation (1G), second-generation (2G), or third-generation (3G) epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) combined with thoracic radiotherapy (TRT). <h4>Methods: </h4> Patients with stage III-IV lung adenocar...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c2ed3c2c-d52f-52df-bcb2-2faadad727aa
DOI
10.21203/rs.3.rs-2111978/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Comparison of the Incidence Rate of Radiation Pneumonitis Observed in Patients with Advanced Lung Adenocarcinoma Treated with Simultaneous Thoracic Radiotherapy and 1G/2G/3G EGFR-TKIsDOI 10.21203/rs.3.rs-2111978/v1
Overlap time is an independent risk factor of radiation pneumonitis for patients treated with simultaneous EGFR-TKI and thoracic radiotherapySemantic proximity
Predicting severe radiation pneumonitis in patients with locally- advanced non-small cell lung cancer after thoracic radiotherapy: Development and internal validation of a nomogram based on the clinical, hematological and dose–volume histogram parametersSemantic proximity
Treatment-Related Pneumonitis of EGFR Tyrosine Kinase Inhibitors Plus Thoracic Radiation Therapy in Patients With Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.Semantic proximity
Thoracic radiotherapy and concurrent almonertinib for unresectable stage III EGFR-mutated non-small-cell lung cancer: a phase 2 study.Semantic proximity
Pneumonitis in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitor: Meta-analysis of 153 cohorts with 15,713 patients: Meta-analysis of incidence and risk factors of EGFR-TKI pneumonitis in NSCLC.Semantic proximity
Constructing a nomogram model for close-range radiotherapy using radioactive 125I particles to treat radiation-induced pneumonia in advanced lung cancerSemantic proximity
Evaluating the Efficacy of EGFR-TKIs Combined With Radiotherapy in Advanced Lung Adenocarcinoma Patients With EGFR Mutation: A Retrospective Study.Semantic proximity
Modeling the Risk of Radiation Pneumonitis in Esophageal Squamous Cell Carcinoma Treated with Definitive ChemoradiotherapySemantic proximity
Radiotherapy combined with EGFR-TKIs for stage III EGFR-Mutated lung cancer: A retrospective cohort studySemantic proximity
Risk analysis of grade ≥ 2 radiation pneumonitis based on radiotherapy timeline in stage III/IV non-small cell lung cancer: a retrospective studySemantic proximity
Radiological Imaging Indicators of Survival in Trachea and Lung Cancers: A Global PerspectiveSemantic proximity
Development of an Ensemble Machine Learning-Based Graphical User Interface (GUI) Tool for Predicting Radiation Pneumonitis in Locally Advanced Squamous Cell Lung Cancer Patients Undergoing Concurrent ChemoradiotherapySemantic proximity
Select a neighboring publication to make it the new centre.